PUBLIC CONTRACT · 2017

Aquisiçao de : Linezolida 600 mg comp Linezolida 600mg/300 ml sol inj fr 300 ml iv

Contract value: €40,423.00
Signed on: 19 January 2017
Procedure: Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 4124618

PUBLISHED DESCRIPTION

510147/17

Parties involved

Contracting body: Centro Hospitalar de Lisboa Central, E. P. E.
Awardee: ACCORD HEALTHCARE, UNIPESSOAL, LDA; TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA
Place of performance: Portugal, Lisboa, Lisboa
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: ACCORD HEALTHCARE, UNIPESSOAL, LDA · Tax ID 508622263
Awardee: TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA · Tax ID 507045491

Values and timeline

Contract price: €40,423.00
Procedure base price: €40,423.00
Total effective price: Not reported on Portal BASE
Publication date: 15 January 2018
Award date: 23 December 2016
Signing date: 19 January 2017
Performance period: 0 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion: Not stated
CPV code: 33600000-6 - Produtos farmacêuticos
Legal basis: Artigo 259.º do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos (DL 18/2008)
Framework agreement: CONCURSO PÚBLICO PARA A CELEBRAÇÃO DE CONTRATOS PÚBLICOS DE APROVISIONAMENTO PARA A ÁREA DA SAÚDE, COM VISTA AO FORNECIMENTO DE MEDICAMENTOS DIVERSOS, ÀS INSTITUIÇÕES E SERVIÇOS DO SERVIÇO NACIONAL DE SAÚDE
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 3168013

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts